CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 56 filers reported holding CARDIFF ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 18.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $313,680 | -9.1% | 224,057 | 0.0% | 0.00% | – |
| Q3 2022 | $345,000 | -30.0% | 224,057 | 0.0% | 0.00% | – |
| Q2 2022 | $493,000 | -18.8% | 224,057 | -8.5% | 0.00% | – |
| Q1 2022 | $607,000 | -59.2% | 244,738 | -1.0% | 0.00% | -100.0% |
| Q4 2021 | $1,486,000 | -9.3% | 247,196 | +0.5% | 0.00% | 0.0% |
| Q3 2021 | $1,638,000 | -23.4% | 245,964 | -23.5% | 0.00% | 0.0% |
| Q2 2021 | $2,139,000 | -13.0% | 321,622 | +21.1% | 0.00% | 0.0% |
| Q1 2021 | $2,459,000 | +739.2% | 265,594 | +1530.0% | 0.00% | – |
| Q4 2020 | $293,000 | – | 16,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 120,600 | $265,000 | 0.37% |
| Artal Group S.A. | 750,000 | $1,650,000 | 0.09% |
| XTX Topco Ltd | 55,081 | $121,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 117,295 | $258,000 | 0.04% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 23,800 | $52,000 | 0.03% |
| Atom Investors LP | 33,798 | $74,000 | 0.03% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 296,507 | $652,000 | 0.03% |
| Laurion Capital Management LP | 722,100 | $1,589,000 | 0.02% |
| MYDA Advisors LLC | 30,000 | $66,000 | 0.02% |
| Ergoteles LLC | 184,000 | $405,000 | 0.01% |